
Teleflex (TFX) Stock Forecast & Price Target
Teleflex (TFX) Analyst Ratings
Bulls say
Teleflex is well-positioned in the medical technology industry, with a diversified product portfolio and a strong presence in the Americas. The company has a solid track record of delivering revenue and EPS beats, and its recent strategic divestitures and cost-saving initiatives are expected to improve its financials in the near future. Furthermore, the appointment of a new CEO with a successful track record in the industry and the company's commitment to sustainability and social responsibility further support a positive outlook for the stock.
Bears say
Teleflex is expected to see a decline in its revenue growth in 2026, which may negatively impact their earnings power. Additionally, any delays or disruptions related to their planned business divestiture could hurt investor sentiment and stock performance. Furthermore, the near-term headwind caused by a third-party supplier recall could lead to elevated back orders and potentially impact full year revenue. The company's CSR framework includes pillars such as ethics and governance, planet and environment, people and human rights, and prosperity and sustainable procurement, which could potentially help their reputation and brand value.
This aggregate rating is based on analysts' research of Teleflex and is not a guaranteed prediction by Public.com or investment advice.
Teleflex (TFX) Analyst Forecast & Price Prediction
Start investing in Teleflex (TFX)
Order type
Buy in
Order amount
Est. shares
0 shares